Profound Medical (TSE:PRN) Hits New 52-Week Low – Time to Sell?

Profound Medical Corp. (TSE:PRN)’s stock price reached a new 52-week low during trading on Friday . The stock traded as low as C$7.00 and last traded at C$6.93, with a volume of 1828 shares traded. The stock had previously closed at C$7.55.

Profound Medical Stock Down 6.6 %

The firm has a market cap of C$17.34 million, a PE ratio of -3.66 and a beta of 1.17. The business has a 50-day moving average price of C$9.44 and a two-hundred day moving average price of C$10.25. The company has a quick ratio of 14.98, a current ratio of 6.12 and a debt-to-equity ratio of 20.05.

Insiders Place Their Bets

In other news, Director Arun Menawat Dr. purchased 14,200 shares of the stock in a transaction on Friday, March 14th. The stock was bought at an average price of C$10.09 per share, for a total transaction of C$143,319.75. 8.62% of the stock is owned by company insiders.

About Profound Medical

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.